Literature DB >> 2992238

Infections in neurosurgery: a randomized comparison between silk and polyglycolic acid.

G C Blomstedt.   

Abstract

Silk or polyglycolic acid (PGA) was chosen at random for 1,011 patients operated on in the department during a 19 month period in 1981. There was no difference in the incidence of serious infections between the two groups. A significantly higher incidence of suture fistulas in the silk group indicates the use of PGA for buried sutures.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2992238     DOI： 10.1007/bf01418466

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


  15 in total

1.  Dexon for sutures and ligatures.

Authors:  A Alveryd; S I Jacobsson
Journal:  Acta Chir Scand       Date:  1975

2.  Clinical experiences with a new synthetic absorbable suture material.

Authors:  H Myllärniemi
Journal:  Ann Chir Gynaecol Fenn       Date:  1971

3.  Effect of suture materials on bacterial survival in infected wounds. An experimental study.

Authors:  B Osterberg; B Blomstedt
Journal:  Acta Chir Scand       Date:  1979

4.  Suture granuloma: an unusual cause of an enhancing ring lesion in the postoperative brain.

Authors:  A J Epstein; E J Russell; L Berlin; G J Novetsky; N Lobo; S H Miller; W Britt
Journal:  J Comput Assist Tomogr       Date:  1982-08       Impact factor: 1.826

5.  [Controlled experimental histological and microbiological studies on the inhibitory effect of polyglycolic acid sutures in infections].

Authors:  A Thiede; L Jostarndt; B Lünstedt; H G Sonntag
Journal:  Chirurg       Date:  1980-01       Impact factor: 0.955

6.  Suture materials and wound infection. An experimental study.

Authors:  B Blomstedt; B Osterberg
Journal:  Acta Chir Scand       Date:  1978

7.  Polyglycolic acid (Dexon) versus silk for fascial closure of abdominal incisions.

Authors:  O Kronborg
Journal:  Acta Chir Scand       Date:  1976

8.  [The effect of various suture materials on wound healing. An experimental study in animals (author's transl)].

Authors:  W L Brückner; H Löweneck
Journal:  MMW Munch Med Wochenschr       Date:  1979-09-28

9.  Polyglycolic acid, silk, and topical ampicillin. Their use in hernia repair and cholecystectomy.

Authors:  J R Andersen; F Burcharth; H W Larsen; O Røder; B Andersen
Journal:  Arch Surg       Date:  1980-03

10.  Absorbable or nonabsorbable suture materials for closure of the dura mater?

Authors:  B Vällfors; H A Hansson; J Svensson
Journal:  Neurosurgery       Date:  1981-10       Impact factor: 4.654
View more
  3 in total

1.  Effect of intra-abdominal absorbable sutures on surgical site infection.

Authors:  Akihiro Watanabe; Shunji Kohnoe; Hideto Sonoda; Ken Shirabe; Kengo Fukuzawa; Soichiro Maekawa; Hiroyuki Matsuda; Masayuki Kitamura; Hiroshi Matsuura; Takeharu Yamanaka; Yoshihiro Kakeji; Shunichi Tsujitani; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Usefulness of absorbable sutures in preventing surgical site infection in hepatectomy.

Authors:  Shinji Togo; Toru Kubota; Takuji Takahashi; Kenichi Yoshida; Kenichi Matsuo; Daisuke Morioka; Kuniya Tanaka; Hiroshi Shimada
Journal:  J Gastrointest Surg       Date:  2008-06       Impact factor: 3.452

Review 3.  Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial.

Authors:  Yoshihiko Maehara; Ken Shirabe; Shunji Kohnoe; Yasunori Emi; Eiji Oki; Yoshihiro Kakeji; Hideo Baba; Masataka Ikeda; Michiya Kobayashi; Tadatoshi Takayama; Shoji Natsugoe; Masashi Haraguchi; Kazuhiro Yoshida; Masanori Terashima; Mitsuru Sasako; Hiroki Yamaue; Norihiro Kokudo; Katsuhiko Uesaka; Shinji Uemoto; Tomoo Kosuge; Yoshiki Sawa; Mitsuo Shimada; Yuichiro Doki; Masakazu Yamamoto; Akinobu Taketomi; Masahiro Takeuchi; Kouhei Akazawa; Takeharu Yamanaka; Mototsugu Shimokawa
Journal:  Surg Today       Date:  2017-02-23       Impact factor: 2.549
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.